Other cell-surface growth factor receptors

The designation "Other cell-surface growth factor receptors" is a non-specific classification used to group various transmembrane receptors that do not fit into primary established families such as the Epidermal Growth Factor Receptor (EGFR) or Vascular Endothelial Growth Factor Receptor (VEGFR) groups. This category typically includes diverse proteins like the Hepatocyte Growth Factor Receptor (MET), Platelet-Derived Growth Factor Receptors (PDGFR), and various orphan receptors that mediate cellular responses to growth factors (IUPHAR/BPS Guide to Pharmacology, 2023). These receptors are integral to signal transduction pathways that regulate essential processes including cell growth, survival, and differentiation (UniProt Consortium, 2024). In many pathological states, particularly oncology, these receptors may be mutated or overexpressed, leading to constitutive signaling and tumor progression. Because this term represents a collection of distinct biological entities rather than a single molecule, it is considered a classification bucket in pharmacological databases rather than a specific therapeutic target for drug development. Analysts should identify the specific receptor member (e.g., MET, KIT, or PDGFR) to accurately assess therapeutic potential and mechanism of action.

Other names

Miscellaneous growth factor receptorsNon-canonical growth factor receptorsOther growth factor receptors

Varies by specific receptor; typically involves inhibition of ligand binding or intracellular tyrosine kinase activity.